share_log
Benzinga ·  May 6 08:33
NRx Pharmaceuticals Announces Final Clinical Trial Results; Believes Demonstration Of Reduced Akathisia In Setting Of Comparable Antidepressant Efficacy Constitutes Basis For Accelerated FDA Approval Of Nrx-101
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment